Arkema today presented to the Central Works Council a detailed project for the new organization of its Jarrie site in France.
The implementation of the PPRT, regulations on the use of mercury electrolysis for chlorine production, and the outlook for certain end-markets require an in-depth reorganization of the Jarrie site.
The project entails the shut-down of the 150kT/year chlorine production using the mercury electrolysis process and its replacement within the next two years or so with 70kT/year membrane electrolysis. This conversion is part of the PPRT’s measures to minimize risk at source, which will help reduce the safety perimeter very significantly and hence the local residents’ exposure to risk. It will also help anticipate the regulations which impose a ban on mercury electrolysis by January 1st 2020.
Additionally, in view of its lack of structural competitiveness and the prospects for its end-markets, the dichloroethane (DCE) plant would also be closed.
Finally, the project will consolidate the industrial world standing of this hydrogen peroxide site through investment in a steam methane reformer (SMR) to help meet demand for hydrogen in hydrogen peroxide manufacture.
The project represents a net investment of some €40M over the next two years for Arkema.
A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, 15,700 employees and 9 research centers, Arkema generates annual revenue of €5.9 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands. The world is our inspiration.